BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15684397)

  • 1. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis.
    Edlund S; Lee SY; Grimsby S; Zhang S; Aspenström P; Heldin CH; Landström M
    Mol Cell Biol; 2005 Feb; 25(4):1475-88. PubMed ID: 15684397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
    Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Methoxyestradiol-induced apoptosis in prostate cancer cells requires Smad7.
    Davoodpour P; Landström M
    J Biol Chem; 2005 Apr; 280(15):14773-9. PubMed ID: 15708859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42.
    Edlund S; Landström M; Heldin CH; Aspenström P
    J Cell Sci; 2004 Apr; 117(Pt 9):1835-47. PubMed ID: 15075243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing.
    Cheon SS; Nadesan P; Poon R; Alman BA
    Exp Cell Res; 2004 Feb; 293(2):267-74. PubMed ID: 14729464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC and Smad7 link TGFβ type I receptors to the microtubule system to promote cell migration.
    Ekman M; Mu Y; Lee SY; Edlund S; Kozakai T; Thakur N; Tran H; Qian J; Groeden J; Heldin CH; Landström M
    Mol Biol Cell; 2012 Jun; 23(11):2109-21. PubMed ID: 22496417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
    Morrison JA; Klingelhutz AJ; Raab-Traub N
    J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
    Band AM; Björklund M; Laiho M
    J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
    Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade.
    Golan T; Yaniv A; Bafico A; Liu G; Gazit A
    J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
    Boyer Arnold N; Korc M
    J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.